Rise in Use of Mobile Computing Devices behind Advent of Telemedicine

San Francisco, California, May 10, 2017: The global market for telemedicine is the focus of analysis of a recent market research report by TMR Research. The report is titled “Telemedicine Market – Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2017–2025.” The capability of telemedicine practices to provide medical assistance to patients living in remote locations, where essential healthcare services are not available or are difficult to reach, is one of the key factors driving the global Telemedicine Market.

Intervention of governments across the globe through funds and incentives aimed at extending the reach of essential medical services across remote locations, increased use of mobile computing devices, and rapid rate of technological advancement of healthcare infrastructure across the globe are some of the chief drivers of the market. Some of the most popular services provided by the telemedicine market are medical education, specialist referral services, and provision of medical and health information to consumers.

Telemedicine is increasingly becoming one of the key segments of the conventional medicine and healthcare market. In the next few years, the market is expected to exhibit an excellent CAGR across developed as well as developing economies.

From a geographical standpoint, the market for telemedicine is presently gaining the most traction and promising growth opportunities in developed economies across North America and Europe. The North America market presently leads and is expected to retain dominance over the report’s forecast period as well. Technology advanced healthcare infrastructures, technologically well-versed population, excellent telecommunication networks, and the presence of a large number of some of the world’s leading companies in the telemedicine field are expected to continue to drive the North America market in the near future.

Over the report’s forecast period, Asia Pacific is expected to present vast growth opportunities to the telemedicine market. The thriving telecommunications industry, rapid rate of technological advancement of the healthcare infrastructure across developing economies, and the vast population will contribute to the growth prospects of the Asia Pacific telemedicine market in the near future.

The vendor landscape of the global telemedicine market is fragmented owing to the presence of a large number of regional as well as international players. Companies in the market are focusing on expanding their geographical reach and offering innovative solutions to attract more consumers to sustain in the highly competitive market. Some of the leading vendors in the market are CISCO Systems, Inc., ARDIOCOM, LLC, Agfa HealthCare NV, CAMD Global Telemedicine, Inc., LifeWatch AG, McKesson Corporation, Polycom Corp., Honeywell HomMed LLC, OBS Medical Ltd., Allscripts Healthcare Solutions, Inc., Medtronic, Inc., F. Hoffmann-La Roche Ltd., InTouch Technologies, Inc., and McKesson Corp.

Rising Geriatric Population Drives Global Tinnitus Incidence

San Francisco, California, May 09, 2017: TMR Research estimates the future of the global tinnitus market with a thorough analysis of the forces governing the market. The report, titled “Tinnitus Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 – 2025,” is a comprehensive take on the strengths bolstering the growth of the overall market and the restrains acting as an impediment. According to the research report, the global tinnitus market is likely to be driven by the growing pool of geriatrics across the globe. The report aims to be a trustworthy account of the milestones the global market has achieved to help the readers understand its trajectory.

Tinnitus refers to the constant ringing sound inside the ears and it is known to affect a large percentage of the population owing to age and deterioration of hearing abilities. Thus, an exponentially rising population of the aged is likely to be an instrumental factor in defining the soaring revenue of the global market. Some of the other causes that lead to tinnitus are ear infections, multiple sclerosis, oxidative stress, wax increase, emotional stress, presence of foreign substance in the ear, nasal allergies, exposure to deafening sounds, and circulatory system disorders.

The increasing awareness of the disease, improving accessibility to healthcare, and rising expenditure on healthcare have collectively influenced the global tinnitus market in positive ways. Additionally, presence of several treatments and drugs for treating tinnitus has also boosted the market growth.

From a geographic point of view, the global tinnitus market is segmented into North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. The report states that North America held a leading position in the global market, which was closely followed by Europe. The high prevalence of tinnitus in the region and better healthcare infrastructure are expected to keep North America in the forefront. On the other hand, Asia Pacific is also expected to emerge as a promising region. The region boasts a huge population with vast and unmet medical needs. The improving economic condition of the regional market and the rising affordability of the people in Asia Pacific are projected to play an important part in the growth of this regional market.

Some of the leading players operating in the global tinnitus market are Abbott Laboratories, Inc., Autifony Therapeutics Limited, Auris Medical AG, Bayer AG, Dr. Willmar Schwabe GmbH & Co. KG, Merz Pharma GmbH & Co. KGaA, MSE Pharmazeutika GmbH, NeuroSystec Corporation, Orasi Medical, Inc., Novartis AG, Sound Pharmaceuticals, Inc., and GlaxoSmithKline PLC. The research report provides an in-depth understanding of the competitive landscape present in the overall market. Furthermore, the analysts have also described the research and development activities undertaken by these players in the global market.

Alarming Rise in Incidence of Zika-related Birth Defects

San Francisco, California, May, 09, 2017: TMR Research presents a new report on the global Zika virus vaccine market for the 2017-2025 period. The report, titled “Zika Virus Vaccines Market – Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2017 – 2025,” report serves as a useful tool for understanding the developmental aspects of global Zika virus vaccine market and its ancillary industries. It provides a detailed description of the vital market indicators and changing competitive hierarchy that are expected to have a bearing on this market for the aforementioned forecast period. Furthermore, the various market segments are studied and growth projections are presented at both regional and global level.

The growing prevalence of Zika virus infection is the primary factor driving the global Zika virus vaccine market. This, along with the increasing incidence of Zika fever is leading to the development of potent vaccines. The rising awareness about treatment option for Zika virus is furthering the market’s growth.

Zika virus infection is transferable. It can pass from an infected mother to her fetus. This results in the infant to be born with microcephaly and other birth defects. This has necessitated the development of vaccines for the prevention of Zika-related birth defects. For example, as per data from Brazilian state authorities, since 2014, more than 1,638 babies in the country were born with microcephaly. The alarming rise in Zika-related birth defects is creating a dire need for development of vaccines to address it.

In November 2016, Zika infection was freed from being an epidemic, as announced by the World Health Organization. The infection is expected to be less prevalent in the coming years, thereby limiting developmental initiatives for Zika virus infection. This, in turn, is restraining the market from realizing its full potential.

The Zika virus vaccine market can be studied with respect to the regional segments of North America, Asia Pacific, Europe, and Rest of the World. Among these, the Rest of the World regional segment is expected to be a significant market during the forecast period. The increasing patient pool suffering from Zika virus infection is the key factor driving the demand for these vaccines in this region. Brazil presently records the highest number of individuals suffering from the infection and is closely followed by Columbia and Venezuela.

The report studies the competitive landscape of the global Zika virus vaccine market at length. Being capital intensive world’s leading drug manufacturers are involved in this industry. This includes Takeda Pharmaceutical Co. Ltd., NewLink Genetics Co., GeneOne Life Science Inc., Sanofi S.A., Hawaii Biotech Inc., Immunovaccine Inc., Bharat Biotech International Ltd., Inovio Pharmaeuticals Inc., and GlaxoSmithKline Plc.

APAC to Gain Spotlight in Mail Service Pharmacy Market

San Francisco, California, May, 09, 2017: The demand in the global mail service pharmacy market is gaining traction from late but apparent penetration of ecommerce in emerging economies, according to a report by TMR Research, and estimates it to expand at a healthy CAGR during the forecast period of 2017 to 2025. The report, titled “Mail Service Pharmacy Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017–2025,” has been prepared to act as a reliable business document for the stakeholders of the market. The report also profiles a number of leading vendors of the mail service pharmacy market to understand the competitive landscape.

As per the findings of the TMR Research report, vast population base in emerging economies such as India and China have realized the benefits offered by mail service pharmacy such as saving time, providing the medicines in comfort of home, and reduced pricing for regular customers. Since mail service pharmacy deals with those often suffering from some medical condition, visiting a pharmacy to buy medicines is not always feasible and hence the growing availability of this facility is escalating the demand. Hospital outlets can also benefit from mail service pharmacy as they deal with large quantity of medicines and new requirements can be swiftly sent electronically to the providers, and essential medicines can be preserved from going out-of-stock. In addition to that, prescriptions can be directly sent to mail service providers who in turn can provide the medicines directly to the preferred location of the patient.

It has also been detected that mail service pharmacies can ensure patients from missing dosages via reminders, providing round-the-clock service, and help in understanding the consumer preference via feedback and online surveys. The presence of several multinational mail service pharmacies across various regions of the world is another factors augmenting the demand in the global mail service pharmacy market. On the other hand, lack of awareness pertaining to the availability of mail service pharmacy is hindering the growth rate of the market.

Geographically, North America currently serves the maximum demand in the global mail service pharmacy market, followed by Europe, which is a reflection of robust healthcare infrastructure and adoptability of new technology. However, with emergence of ecommerce in vastly populated Asia Pacific, the demand from this region is expected to escalate at a rapid rate during the forecast period.

Walgreen Co., Walgreen Co., Justia, OptumRx, Inc., PBM Plus, Inc., Blue Shield of California, Fairview Health Services, WellCare, Inc., United HealthCare Services, Inc., Blue Cross and Blue Shield of Massachusetts, Inc., Blue Cross And Blue Shield Association, Wal-Mart Stores, Inc., and Caremark, L.L.C., are some of the leading companies currently functional in the global mail service pharmacy market.